Record

RefNoEC/1992/34
LevelItem
TitleTownsend, Alain Robert Michael: certificate of election to the Royal Society
Date1991
DescriptionCitation typed
CitationDistinguished for his studies on cytotoxic T cells (CTL) and their recognition of viral components restricted by class I MHC molecules. Using influenza as a model system, he discovered that the viral internal nucleoprotein is an important target antigen for murine CTL - a finding which was subsequently shown to be generally applicable both to other viruses and to human CTL. In further experiments he demonstrated that CTL could recognise the viral nucleoprotein gene product in the absence of signal sequences and that targets transfected with truncated nucleoprotein genes were also recognised. These findings led to the seminal discovery that epitopes seen by class I restricted CTL can be defined by small peptides. Recent collaborative work with K. Karre using mouse and human mutant cell lines that are unable to express surface MHC, has led to the important observation that appropriate peptide epitopes are required for the stable assembly of class I MHC molecules.
AccessStatusClosed
Add to My Items

    Collection highlights

    Browse the records of some of our collections, which cover all branches of science and date from the 12th century onwards. These include the published works of Fellows of the Royal Society, personal papers of eminent scientists, letters and manuscripts sent to the Society or presented at meetings, and administrative records documenting the Society's activities since our foundation in 1660.

    The Royal Society

    The Royal Society is a Fellowship of many of
    the world's most eminent scientists and is the
    oldest scientific academy in continuous existence.
    Registered charity number 207043

    Website design ©CalmView



    CONTACT US

    + 44 207 451 2500
    (Lines open Mon-Fri, 9:00-17:00. Excludes bank holidays)

    6-9 Carlton House Terrace, London SW1Y 5AG

    Email Us →

    SUBSCRIBE

    Subscribe to our newsletters to be updated with the
    latest news on innovation, events, articles and reports.

    Subscribe →

    © CalmView